Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine, Tramadol, or Buprenorphine-Naloxone for Opioid Detoxification
NCT03678792Phase 3Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Nov 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of morphine, tramadol in opioid use disorder (OUD), opioid withdrawal, sponsored by University of Alabama at Birmingham. Planned start Nov 2019; status: withdrawn.
02
Drugs
morphinetramadol
03
Conditions
opioid use disorder (OUD)opioid withdrawal
Beyond the preview
Go deeper on NCT03678792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03678792.